NCT06357234 - Aprepitant Treatment to Prevent Postoperative Nausea and Vomiting in Children Undergoing Scoliosis Surgery | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

March 17, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

September 30, 2027

Conditions

Spinal FusionNausea and Vomiting, PostoperativeAnesthesia

Interventions

DRUG

Aprepitant

Two doses of 40mg (2ml) Aprepitant. One to be given on the morning of surgery and the second on the morning of post-op day 1

DRUG

Placebo

Two doses of dextrose syrup (2ml). One to be given on the morning of surgery and the second on the morning of post-op day 1

Trial Locations (1)

RECRUITING

IWK Health Sciences Center, Halifax